Literature DB >> 17301814

Comparison of whole blood vs purified blood granulocytes for the detection and quantitation of JAK2(V617F).

S Hermouet, I Dobo, E Lippert, M-C Boursier, L Ergand, F Perrault-Hu, D Pineau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17301814     DOI： 10.1038/sj.leu.2404588

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  Concordance of assays designed for the quantification of JAK2V617F: a multicenter study.

Authors:  Eric Lippert; François Girodon; Emma Hammond; Jaroslav Jelinek; N Scott Reading; Boris Fehse; Katy Hanlon; Mirjam Hermans; Céline Richard; Sabina Swierczek; Valérie Ugo; Serge Carillo; Véronique Harrivel; Christophe Marzac; Daniela Pietra; Marta Sobas; Morgane Mounier; Marina Migeon; Sian Ellard; Nicolaus Kröger; Richard Herrmann; Josef T Prchal; Radek C Skoda; Sylvie Hermouet
Journal:  Haematologica       Date:  2008-11-10       Impact factor: 9.941

2.  A real-time polymerase chain reaction assay for rapid, sensitive, and specific quantification of the JAK2V617F mutation using a locked nucleic acid-modified oligonucleotide.

Authors:  Barbara Denys; Hakim El Housni; Friedel Nollet; Bruno Verhasselt; Jan Philippé
Journal:  J Mol Diagn       Date:  2010-04-29       Impact factor: 5.568

3.  A sensitive detection method for MPLW515L or MPLW515K mutation in chronic myeloproliferative disorders with locked nucleic acid-modified probes and real-time polymerase chain reaction.

Authors:  Alessandro Pancrazzi; Paola Guglielmelli; Vanessa Ponziani; Gaetano Bergamaschi; Alberto Bosi; Giovanni Barosi; Alessandro M Vannucchi
Journal:  J Mol Diagn       Date:  2008-07-31       Impact factor: 5.568

4.  Quantitative assay for the detection of the V617F variant in the Janus kinase 2 (JAK2) gene using the Luminex xMAP technology.

Authors:  François W Paradis; Raynald Simard; Daniel Gaudet
Journal:  BMC Med Genet       Date:  2010-04-01       Impact factor: 2.103

5.  CRISPR/Cas12a-Based Ultrasensitive and Rapid Detection of JAK2 V617F Somatic Mutation in Myeloproliferative Neoplasms.

Authors:  Miaomiao Chen; Chunhua Zhang; Zhiqing Hu; Zhuo Li; Menglin Li; Lingqian Wu; Miaojin Zhou; Desheng Liang
Journal:  Biosensors (Basel)       Date:  2021-07-24

6.  Impact of JAK2 V617F mutation on hemogram variation in patients with non-reactive elevated platelet counts.

Authors:  Juan Zhou; Yuanxin Ye; Shugen Zeng; Yi Zhou; Zhigang Mao; Xingbo Song; Binwu Ying; Xiaojun Lu; Hong Jiang; Lanlan Wang
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.